Folate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture Therapy

<p>Abstract</p> <p>Boron neutron capture therapy (BNCT) is increasingly being used in the treatment of several aggressive cancers, including cerebral glioblastoma multiforme. The main requirement for this therapy is selective targeting of tumor cells by sufficient quantities of<...

Full description

Bibliographic Details
Main Authors: Ciofani Gianni, Raffa Vittoria, Menciassi Arianna, Cuschieri Alfred
Format: Article
Language:English
Published: SpringerOpen 2008-01-01
Series:Nanoscale Research Letters
Subjects:
Online Access:http://dx.doi.org/10.1007/s11671-008-9210-9
_version_ 1827882946190639104
author Ciofani Gianni
Raffa Vittoria
Menciassi Arianna
Cuschieri Alfred
author_facet Ciofani Gianni
Raffa Vittoria
Menciassi Arianna
Cuschieri Alfred
author_sort Ciofani Gianni
collection DOAJ
description <p>Abstract</p> <p>Boron neutron capture therapy (BNCT) is increasingly being used in the treatment of several aggressive cancers, including cerebral glioblastoma multiforme. The main requirement for this therapy is selective targeting of tumor cells by sufficient quantities of<sup>10</sup>B atoms required for their capture/irradiation with low-energy thermal neutrons. The low content of boron targeting species in glioblastoma multiforme accounts for the difficulty in selective targeting of this very malignant cerebral tumor by this radiation modality. In the present study, we have used for the first time boron nitride nanotubes as carriers of boron atoms to overcome this problem and enhance the selective targeting and ablative efficacy of BNCT for these tumors. Following their dispersion in aqueous solution by noncovalent coating with biocompatible poly-<smcaps>l</smcaps>-lysine solutions, boron nitride nanotubes were functionalized with a fluorescent probe (quantum dots) to enable their tracking and with folic acid as selective tumor targeting ligand. Initial in vitro studies have confirmed substantive and selective uptake of these nanovectors by glioblastoma multiforme cells, an observation which confirms their potential clinical application for BNCT therapy for these malignant cerebral tumors.</p>
first_indexed 2024-03-12T19:04:30Z
format Article
id doaj.art-a9f86bd9877f4a1a8482b2266a8fa869
institution Directory Open Access Journal
issn 1931-7573
1556-276X
language English
last_indexed 2024-03-12T19:04:30Z
publishDate 2008-01-01
publisher SpringerOpen
record_format Article
series Nanoscale Research Letters
spelling doaj.art-a9f86bd9877f4a1a8482b2266a8fa8692023-08-02T06:23:37ZengSpringerOpenNanoscale Research Letters1931-75731556-276X2008-01-0142113121Folate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture TherapyCiofani GianniRaffa VittoriaMenciassi AriannaCuschieri Alfred<p>Abstract</p> <p>Boron neutron capture therapy (BNCT) is increasingly being used in the treatment of several aggressive cancers, including cerebral glioblastoma multiforme. The main requirement for this therapy is selective targeting of tumor cells by sufficient quantities of<sup>10</sup>B atoms required for their capture/irradiation with low-energy thermal neutrons. The low content of boron targeting species in glioblastoma multiforme accounts for the difficulty in selective targeting of this very malignant cerebral tumor by this radiation modality. In the present study, we have used for the first time boron nitride nanotubes as carriers of boron atoms to overcome this problem and enhance the selective targeting and ablative efficacy of BNCT for these tumors. Following their dispersion in aqueous solution by noncovalent coating with biocompatible poly-<smcaps>l</smcaps>-lysine solutions, boron nitride nanotubes were functionalized with a fluorescent probe (quantum dots) to enable their tracking and with folic acid as selective tumor targeting ligand. Initial in vitro studies have confirmed substantive and selective uptake of these nanovectors by glioblastoma multiforme cells, an observation which confirms their potential clinical application for BNCT therapy for these malignant cerebral tumors.</p>http://dx.doi.org/10.1007/s11671-008-9210-9Boron nitride nanotubesFolateGlioblastoma multiformeBoron neutron capture therapy
spellingShingle Ciofani Gianni
Raffa Vittoria
Menciassi Arianna
Cuschieri Alfred
Folate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture Therapy
Nanoscale Research Letters
Boron nitride nanotubes
Folate
Glioblastoma multiforme
Boron neutron capture therapy
title Folate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture Therapy
title_full Folate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture Therapy
title_fullStr Folate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture Therapy
title_full_unstemmed Folate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture Therapy
title_short Folate Functionalized Boron Nitride Nanotubes and their Selective Uptake by Glioblastoma Multiforme Cells: Implications for their Use as Boron Carriers in Clinical Boron Neutron Capture Therapy
title_sort folate functionalized boron nitride nanotubes and their selective uptake by glioblastoma multiforme cells implications for their use as boron carriers in clinical boron neutron capture therapy
topic Boron nitride nanotubes
Folate
Glioblastoma multiforme
Boron neutron capture therapy
url http://dx.doi.org/10.1007/s11671-008-9210-9
work_keys_str_mv AT ciofanigianni folatefunctionalizedboronnitridenanotubesandtheirselectiveuptakebyglioblastomamultiformecellsimplicationsfortheiruseasboroncarriersinclinicalboronneutroncapturetherapy
AT raffavittoria folatefunctionalizedboronnitridenanotubesandtheirselectiveuptakebyglioblastomamultiformecellsimplicationsfortheiruseasboroncarriersinclinicalboronneutroncapturetherapy
AT menciassiarianna folatefunctionalizedboronnitridenanotubesandtheirselectiveuptakebyglioblastomamultiformecellsimplicationsfortheiruseasboroncarriersinclinicalboronneutroncapturetherapy
AT cuschierialfred folatefunctionalizedboronnitridenanotubesandtheirselectiveuptakebyglioblastomamultiformecellsimplicationsfortheiruseasboroncarriersinclinicalboronneutroncapturetherapy